Management of the acute migraine episode with sumatriptan vs. metoclopramide

@inproceedings{SalazarZiga2006ManagementOT,
  title={Management of the acute migraine episode with sumatriptan vs. metoclopramide},
  author={Abelardo Salazar-Z{\'u}{\~n}iga and Alfonso Garfias-Arvizu},
  year={2006}
}
  • Abelardo Salazar-Zúñiga, Alfonso Garfias-Arvizu
  • Published 2006
P<0.01. Results. The use of metoclopramide reduced the headache from level 3 to levels 0 or 1 in the first 15 min in 70% of the cases, while sumatriptan reduced the headache in only 58% of the patients. The autonomic symptoms associated with migraine (nausea and vomiting) respond better to metoclopramide. Furthermore, it has less secondary effects than sumatriptan. Conclusions. In this study metoclopramide was more effective in alleviating the acute phase of migraine, and had less secondary… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 32 references

Selective serotonin 1 F ( 5 - HT 1 F ) receptor agonist LY 334370 for acute migraine : a randomized controlled trial

  • G Fulgraff, G NeumannH, P Wollenberg, W Forth, KI Roon, WW Offen
  • BJP
  • 2005

Headache classification update

  • Saper
  • Curr Opin Neurol
  • 2004

Dexamethasone decrease migraine recurrence observed after treatment with a tryptan combined with nonsteroidal antiinflamatory drug

  • AV Krymchamtowsky, JS Barbosa
  • Am J Emerg Med
  • 2003

A prospective double blind study of nasal sumatriptan vs Ketorolac in migraine headache

  • JT Meredith, S Wait, KL Brewer
  • J Emerg Med
  • 2002

Similar Papers

Loading similar papers…